Article Cited by others


PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

Edlind Merritt P, Hsieh Andrew C

Year : 2014| Volume: 16| Issue : 3 | Page no: 378-386

   This article has been cited by
1 Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer
Cuicui Zhu,Qingyi Zhu,Zhaomeng Wu,Yingying Yin,Dan Kang,Shan Lu,Ping Liu
Journal of Cellular Physiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Protein kinase B
Bhumika Wadhwa,Ubaid Makhdoomi,Ram Vishwakarma,Fayaz Malik
Anti-Cancer Drugs. 2017; 28(6): 569
[Pubmed]  [Google Scholar] [DOI]
3 MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG
Miao Wang,Wei Gao,Dehong Lu,Lianghong Teng
Pathology & Oncology Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 AR Signaling and the PI3K Pathway in Prostate Cancer
Megan Crumbaker,Leila Khoja,Anthony Joshua
Cancers. 2017; 9(4): 34
[Pubmed]  [Google Scholar] [DOI]
5 Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways
Ewelina Górowska-Wójtowicz,Anna Hejmej,Alicja Kaminska,Laura Pardyak,Malgorzata Kotula-Balak,Joanna Dulinska-Litewka,Piotr Laidler,Barbara Bilinska
Toxicology in Vitro. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A
Xiaodi Qiu,Ying Dou
Biomedicine & Pharmacotherapy. 2017; 88: 430
[Pubmed]  [Google Scholar] [DOI]
7 Mechanisms of Therapeutic Resistance in Prostate Cancer
Mary Nakazawa,Channing Paller,Natasha Kyprianou
Current Oncology Reports. 2017; 19(2)
[Pubmed]  [Google Scholar] [DOI]
8 Investigational serine/threonine kinase inhibitors against prostate cancer metastases
Claudio Festuccia
Expert Opinion on Investigational Drugs. 2017; 26(1): 25
[Pubmed]  [Google Scholar] [DOI]
9 Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3ß in a hamster model of oral oncogenesis
Josephraj Sophia,Kranthi Kiran Kishore T.,Jaganathan Kowshik,Rajakishore Mishra,Siddavaram Nagini
Scientific Reports. 2016; 6: 22192
[Pubmed]  [Google Scholar] [DOI]
10 Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro
Jasmina Makarevic,Igor Tsaur,Eva Juengel,Hendrik Borgmann,Karen Nelson,Christian Thomas,Georg Bartsch,Axel Haferkamp,Roman A. Blaheta
Life Sciences. 2016; 147: 137
[Pubmed]  [Google Scholar] [DOI]
11 Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Pier-Luc Clermont,Francesco Crea,Yan Ting Chiang,Dong Lin,Amy Zhang,James Z. L. Wang,Abhijit Parolia,Rebecca Wu,Hui Xue,Yuwei Wang,Jiarui Ding,Kelsie L. Thu,Wan L. Lam,Sohrab P. Shah,Colin C. Collins,Yuzhuo Wang,Cheryl D. Helgason
Clinical Epigenetics. 2016; 8(1)
[Pubmed]  [Google Scholar] [DOI]
12 Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
S. Sideris,F. Aoun,C. N. Martinez,S. Latifyan,A. Awada,G. Costante,T. Gil
Journal of Endocrinological Investigation. 2016;
[Pubmed]  [Google Scholar] [DOI]
13 Determination of MLN0128, an investigational antineoplastic agent, in human plasma by LC-MS/MS
Sandeep R. Kunati,Yan Xu
Biomedical Chromatography. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression
Xuechao Wan,Wenhua Huang,Shu Yang,Yalong Zhang,Pu Zhang,Zhe Kong,Tao Li,Hai Wu,Fengxiang Jing,Yao Li
The International Journal of Biochemistry & Cell Biology. 2016; 79: 249
[Pubmed]  [Google Scholar] [DOI]
15 Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
Patricia Mucci LoRusso
Journal of Clinical Oncology. 2016; 34(31): 3803
[Pubmed]  [Google Scholar] [DOI]
16 Discovery of 4-(Piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine Derivatives as Akt Inhibitors
Yang Liu,Yanzhen Yin,Jingya Zhang,Krystle Nomie,Liang Zhang,Dezhi Yang,Michael L. Wang,Guisen Zhao
Archiv der Pharmazie. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
17 mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review
Cara M. Statz,Sara E. Patterson,Susan M. Mockus
Targeted Oncology. 2016;
[Pubmed]  [Google Scholar] [DOI]
18 The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
C Morell,A Bort,D Vara,A Ramos-Torres,N Rodríguez-Henche,I Díaz-Laviada
Prostate Cancer and Prostatic Diseases. 2016;
[Pubmed]  [Google Scholar] [DOI]
19 Effects of Brassicaceae Isothiocyanates on Prostate Cancer
Silvia Novío,María Cartea,Pilar Soengas,Manuel Freire-Garabal,María Núñez-Iglesias
Molecules. 2016; 21(5): 626
[Pubmed]  [Google Scholar] [DOI]
20 Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
A. C. Hsieh,H. G. Nguyen,L. Wen,M. P. Edlind,P. R. Carroll,W. Kim,D. Ruggero
Science Signaling. 2015; 8(403): ra116
[Pubmed]  [Google Scholar] [DOI]
21 The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence
David Schörghofer,Katharina Kinslechner,Andrea Preitschopf,Birgit Schütz,Clemens Röhrl,Markus Hengstschläger,Herbert Stangl,Mario Mikula
Reproductive Biology and Endocrinology. 2015; 13(1)
[Pubmed]  [Google Scholar] [DOI]
22 PI3K/Akt signaling in osteosarcoma
Jian Zhang,Xiao-Hua Yu,Yi-Guo Yan,Cheng Wang,Wen-Jun Wang
Clinica Chimica Acta. 2015; 444: 182
[Pubmed]  [Google Scholar] [DOI]
23 VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo
Zheren Shao,Qi Bao,Fangzhen Jiang,Huan Qian,Quan Fang,Xueqing Hu,Cong Cao
PLOS ONE. 2015; 10(7): e0132655
[Pubmed]  [Google Scholar] [DOI]
24 An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients
Jianqing Lin,Aileen Deng,Jean Hoffman-Censits,Geoffrey Gibney,Terry Hyslop,Brooke Miller,Deborah Kilpatrick,Serge Jabbour,William Kevin Kelly
Cancer Treatment Communications. 2015; 4: 192
[Pubmed]  [Google Scholar] [DOI]
25 Persistent androgen receptor addiction in castration-resistant prostate cancer
Michael T. Schweizer,Evan Y. Yu
Journal of Hematology & Oncology. 2015; 8(1)
[Pubmed]  [Google Scholar] [DOI]
26 Transcription factor and microRNA-regulated network motifs for cancer and signal transduction networks
Wen-Tsong Hsieh,Ke-Rung Tzeng,Jin-Shuei Ciou,Jeffrey JP Tsai,Nilubon Kurubanjerdjit,Chien-Hung Huang,Ka-Lok Ng
BMC Systems Biology. 2015; 9(Suppl 1): S5
[Pubmed]  [Google Scholar] [DOI]
27 Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors
Riccardo Zanni,Maria Galvez-Llompart,Cecilia Morell,Nieves Rodríguez-Henche,Inés Díaz-Laviada,Maria Carmen Recio-Iglesias,Ramon Garcia-Domenech,Jorge Galvez,Yuan-Soon Ho
PLOS ONE. 2015; 10(4): e0124244
[Pubmed]  [Google Scholar] [DOI]
28 HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells
Haitao Wang,Guanzhong Liu,Dan Shen,Huamao Ye,Jinming Huang,Li Jiao,Yinghao Sun
Oncology Reports. 2015;
[Pubmed]  [Google Scholar] [DOI]
29 Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo
Shang-jun Jiang,Shuo Wang
Tumor Biology. 2015; 36(10): 8177
[Pubmed]  [Google Scholar] [DOI]
30 Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation
Bodo Melnik
International Journal of Molecular Sciences. 2015; 16(8): 17048
[Pubmed]  [Google Scholar] [DOI]
31 Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling
Haitao Liu,Yubin Wang,Ashok Sharma,Rui Mao,Na Jiang,Boying Dun,Jin-Xiong She
Anti-Cancer Drugs. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
32 PIP5K1  inhibition as a therapeutic strategy for prostate cancer
J. M. Drake,J. Huang
Proceedings of the National Academy of Sciences. 2014; 111(35): 12578
[Pubmed]  [Google Scholar] [DOI]


Read this article